RPAM
ASTH icon

Rhenman & Partners Asset Management’s Astrana Health ASTH Stock Holding History

Rhenman & Partners Asset Management’s Portfolio ASTH Stock Details ASTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-190,000
Closed -$4.73M – 103
2025
Q2 		$4.73M Buy
190,000
+40,000
+27% +$1.13M 0.6% 50
2025
Q1 		$4.65M Buy
150,000
+70,000
+88% +$2.33M 0.53% 47
2024
Q4 		$2.52M Buy
+80,000
New +$3.8M 0.26% 74

Other funds holding ASTH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
3C
325 Capital New York $274M AUM 49.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Rhenman & Partners Asset Management's ASTH Position: Q3 2025 in Review

Rhenman & Partners Asset Management sold out of Astrana Health (ASTH) in Q3 2025, closing a stake of 190,000 shares — an estimated $4.73M sold.

Rhenman & Partners Asset Management first reported a position in ASTH in Q4 2024 and held it in 3 quarters. The position peaked at $4.73M in Q2 2025. 188 funds tracked by Wall St. Rank hold ASTH as of Q3 2025.

  • Rhenman & Partners Asset Management reported no remaining Astrana Health position as of Q3 2025 after selling out during the quarter.
  • Rhenman & Partners Asset Management sold 190,000 Astrana Health shares in Q3 2025, an estimated $4.73M.
  • Rhenman & Partners Asset Management first reported a position in Astrana Health in Q4 2024 and held it in 3 quarters.
  • Rhenman & Partners Asset Management's Astrana Health position peaked at $4.73M in Q2 2025.
  • 188 funds tracked by Wall St. Rank held Astrana Health as of Q3 2025.

Based on Rhenman & Partners Asset Management's 13F filing for Q3 2025, filed 13 Nov 2025.